Living well with PI: Impact of federal policy changes on the PI community
Time to diagnosis is critical in PI health outcomes
Living well with PI: Impact of federal policy changes on the PI community
Bold Conversations: The elephant in the exam room
Spring 2025 IDF ADVOCATE newsletter
Yimmugo
Administration: IVIG
Concentration: 10% (100 mg/mL)
Approved for: Ages 2+
Kedrion distributes Yimmugo in the U.S.
Report side effects/adverse reactions at 1-855-353-7466 or https://www.kedrion.us/ pharmacovigilance/.
Thirty-year-old with APS type 1 advocates for her community
Decoding PI: The science of gene therapy and gene editing
Susan finds "priceless" support system in the Immune Deficiency Foundation

